Experiences of Patients With Atrial Fibrillation With Combination Antithrombotic Therapy Post–Percutaneous Coronary Intervention

BACKGROUND: Up to 30% of patients with atrial fibrillation (AF) have coronary artery disease, and many undergo percutaneous coronary intervention (PCI). In the setting of acute coronary syndrome with PCI, or high-risk elective PCI, Canadian AF guidelines recommend 1-30 days of acetylsalicylic acid,...

Descripción completa

Detalles Bibliográficos
Autores principales: Poirier, Caylie M., Carter, Aleesa A., Kwan, Yvonne, Koo, Jessica, Westlund, Jill M., Alkass, Fadi, Leblanc, Kori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679455/
https://www.ncbi.nlm.nih.gov/pubmed/38020330
http://dx.doi.org/10.1016/j.cjco.2023.08.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679455/
https://www.ncbi.nlm.nih.gov/pubmed/38020330
http://dx.doi.org/10.1016/j.cjco.2023.08.007

Ejemplares similares